Literature DB >> 10385255

Pharmacological analysis of CCK2 receptor antagonists using isolated rat stomach ECL cells.

E Lindström1, M Björkqvist, R Håkanson.   

Abstract

1. Gastrin stimulates rat stomach ECL cells to secrete histamine and pacreastatin, a chromogranin A (CGA)-derived peptide. The present report describes the effect of nine cholecystokinin2 (CCK2) receptor antagonists and one CCK1 receptor antagonist on the gastrin-evoked secretion of pancreastatin from isolated ECL cells. 2. The CCK2 receptor antagonists comprised three benzodiazepine derivatives L-740,093, YM022 and YF476, one ureidoacetamide compound RP73870, one benzimidazole compound JB 93182, one ureidoindoline compound AG041R and three tryptophan dipeptoids PD 134308 (CI988), PD135158 and PD 136450. The CCK1 receptor antagonist was devazepide. 3. A preparation of well-functioning ECL cells (approximately 80% purity) was prepared from rat oxyntic mucosa using counter-flow elutriation. The cells were cultured for 48 h in the presence of 0.1 nM gastrin; they were then washed and incubated with antagonist alone or with various concentrations of antagonist plus 10 nM gastrin (a maximally effective concentration) for 30 min. Gastrin dose-response curves were constructed in the absence or presence of increasing concentrations of antagonist. The amount of pancreastatin secreted was determined by radioimmunoassay. 4. The gastrin-evoked secretion of pancreastatin was inhibited in a dose-dependent manner. YM022, AG041R and YF476 had IC50 values of 0.5, 2.2 and 2.7 nM respectively. L-740,093, JB93182 and RP73870 had IC50 values of 7.8, 9.3 and 9.8 nM, while PD135158, PD136450 and PD134308 had IC50 values of 76, 135 and 145 nM. The CCK1 receptor antagonist devazepide was a poor CCK2 receptor antagonist with an IC50 of about 800 nM. 5. YM022, YF476 and AG041R were chosen for further analysis. YM022 and YF476 shifted the gastrin dose-response curve to the right in a manner suggesting competitive antagonism, while the effects of AG041R could not be explained by simple competitive antagonism. pK(B) values were 11.3 for YM022, 10.8 for YF476 and the apparent pK(B) for AG041R was 10.4.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10385255      PMCID: PMC1566020          DOI: 10.1038/sj.bjp.0702538

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  60 in total

1.  YM022 [(R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo-5-phenyl-1H-1,4- benzodiazepin-3-yl]-3-(3-methylphenyl)urea]: an irreversible cholecystokinin type-B receptor antagonist.

Authors:  J Dunlop; N Brammer; N Evans; C Ennis
Journal:  Biochem Pharmacol       Date:  1997-07-01       Impact factor: 5.858

2.  Further concerns over Cheng-Prusoff analysis.

Authors:  P Leff; I G Dougall
Journal:  Trends Pharmacol Sci       Date:  1993-04       Impact factor: 14.819

3.  Characterization of cloned human cholecystokinin-B receptor as a gastrin receptor.

Authors:  A Miyake; S Mochizuki; H Kawashima
Journal:  Biochem Pharmacol       Date:  1994-04-20       Impact factor: 5.858

4.  Cholecystokinin type B receptor antagonist PD-136,450 is a partial secretory agonist in the stomach and a full agonist in the pancreas of the rat.

Authors:  A Schmassmann; A Garner; B Flogerzi; M Y Hasan; M Sanner; L Varga; F Halter
Journal:  Gut       Date:  1994-02       Impact factor: 23.059

5.  Histamine secretion from rat enterochromaffinlike cells.

Authors:  C Prinz; M Kajimura; D R Scott; F Mercier; H F Helander; G Sachs
Journal:  Gastroenterology       Date:  1993-08       Impact factor: 22.682

6.  A single amino acid of the cholecystokinin-B/gastrin receptor determines specificity for non-peptide antagonists.

Authors:  M Beinborn; Y M Lee; E W McBride; S M Quinn; A S Kopin
Journal:  Nature       Date:  1993-03-25       Impact factor: 49.962

7.  Gastrin receptor genes are expressed in gastric parietal and enterochromaffin-like cells of Mastomys natalensis.

Authors:  M Asahara; Y Kinoshita; H Nakata; Y Matsushima; Y Naribayashi; A Nakamura; T Matsui; K Chihara; J Yamamoto; A Ichikawa
Journal:  Dig Dis Sci       Date:  1994-10       Impact factor: 3.199

8.  Pharmacological profile of (R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo- 5-phenyl-1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea (YM022), a new potent and selective gastrin/cholecystokinin-B receptor antagonist, in vitro and in vivo.

Authors:  A Nishida; K Miyata; R Tsutsumi; H Yuki; S Akuzawa; A Kobayashi; T Kamato; H Ito; M Yamano; Y Katuyama
Journal:  J Pharmacol Exp Ther       Date:  1994-05       Impact factor: 4.030

9.  Acute responses of rat stomach enterochromaffinlike cells to gastrin: secretory activation and adaptation.

Authors:  D Chen; H J Monstein; A G Nylander; C M Zhao; F Sundler; R Håkanson
Journal:  Gastroenterology       Date:  1994-07       Impact factor: 22.682

Review 10.  The biology and pathobiology of the ECL cells.

Authors:  R Håkanson; Y Tielemans; D Chen; K Andersson; B Ryberg; H Mattsson; F Sundler
Journal:  Yale J Biol Med       Date:  1992 Nov-Dec
View more
  6 in total

1.  Mobilization of rat stomach ECL-cell histamine in response to short- or long-term treatment with omeprazole and/or YF 476 studied by gastric submucosal microdialysis in conscious rats.

Authors:  T Konagaya; M Bernsand; P Norlén; R Håkanson
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

2.  Thermodynamic analysis of ligands at cholecystokinin CCK2 receptors in rat cerebral cortex.

Authors:  E A Harper; S P Roberts; S B Kalindjian
Journal:  Br J Pharmacol       Date:  2007-06-25       Impact factor: 8.739

3.  Long-lasting cholecystokinin(2) receptor blockade after a single subcutaneous injection of YF476 or YM022.

Authors:  M Kitano; P Norlén; X Q Ding; S Nakamura; R Håkanson
Journal:  Br J Pharmacol       Date:  2000-06       Impact factor: 8.739

4.  Gastrin and D1 dopamine receptor interact to induce natriuresis and diuresis.

Authors:  Yue Chen; Laureano D Asico; Shuo Zheng; Van Anthony M Villar; Duofen He; Lin Zhou; Chunyu Zeng; Pedro A Jose
Journal:  Hypertension       Date:  2013-09-09       Impact factor: 10.190

5.  The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

6.  Gastrin and the neuropeptide PACAP evoke secretion from rat stomach histamine-containing (ECL) cells by stimulating influx of Ca2+ through different Ca2+ channels.

Authors:  E Lindström; L Eliasson; M Björkqvist; R Håkanson
Journal:  J Physiol       Date:  2001-09-15       Impact factor: 5.182

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.